Zhonggong Education: Director Yi Ziting resigned due to retirement. Zhonggong Education announced that the company's board of directors recently received a written resignation report from Director Yi Ziting. Yi Ziting applied to the company's board of directors for resignation due to retirement, and will not hold other positions in the company after resignation.The number of employed people in Australia increased by 35,613 in November, and it is estimated to be 25,000.US President-elect Trump: Opposing Ukrainian armed forces to attack Russia with US long-range missiles has further escalated the conflict.
Xia Yiping, CEO of Extreme Vietnam: I am only a minority shareholder of the company, and Baidu has 80% of the voting rights. I learned from employees inside Extreme Vietnam that Xia Yiping, CEO of Extreme Vietnam, communicated with employee representatives about the company this afternoon. He revealed that the board of directors had a meeting the night before the 11th solution was released, and no agreement was reached on employee social security. It is not up to you to decide the plan that is released only after you get the resolution from the board of directors. "I said that I could take some money to solve the social security problem of employees, but in this case, neither shareholder stood up." He said that he is the CEO of the company, but he is only a minority shareholder and has decision-making power in business, but he has no decision-making power in the development of the company and needs the decision of the board of directors. 80% of the voting rights of the company are in Baidu. Baidu has just conducted a comprehensive audit of the company recently, and there are no problems. (Sina Technology)The Southern CSI A500ETF Link Fund was added with Y share, which was included in the list of individual pensions. Four products from southern fund were shortlisted for individual pensions, including the Southern CSI A500ETF Link Fund, and Y share was added with code 022918. Its target ETF-CSI A500ETF South (159352) has received a net inflow of funds for 38 consecutive days, with the latest scale approaching 19 billion yuan. According to the data of China Merchants Securities Fund Evaluation Center, in the past 10 years, South Stock ETF has been the most accurate in tracking, ranking first in its kind. Investors can borrow the layout of the A500ETF South (159352) and its linked funds (A 022434, C 022435, Y 022918).Market News: South Korean President Yin Xiyue may release a recorded public speech.
Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.Huichuan technology: the company has started to apply AI technology in the field of machine vision. Huichuan technology said at the performance briefing that in the field of AI: the company has started to apply AI technology in the field of machine vision, and the exploration in other fields will be carried out according to customer needs and industrial development. In the field of humanoid robots: the company is currently led by the product competitiveness center, and multi-departments cooperate to develop core components such as motors, drivers and actuator modules. The spin-off and listing of the company's subsidiary, United Power, is progressing steadily and is still in the stage of listing counseling.The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.
Strategy guide
12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14